236 
Market Cap
Stock Chart
Anteo Diagnostics - 30 Day Poll
Recent BLOGS About Anteo Diag. Add New
Latest Company News
|
Anteo Diagnostics Ltd Announces Grant Of Patent In The United States
Reuters Key Development - May 4, 2012 |
|
Anteo Diagnostics Ltd Exercises Options Into New Ordinary Shares
Reuters Key Development - Apr 2, 2012 |
|
Anteo Diagnostics Ltd Signs Patent And Technology License Agreement With eBioscience
Reuters Key Development - Mar 13, 2012 |
|
Anteo Diagnostics Ltd Converts Options Into New Ordinary Shares
Reuters Key Development - Jun 25, 2011 |
Website
Videos related to Anteo Diag.
Company Profile
Cash: approx. $5.5 million Dec 2011.
Anteo Diagnostics Limited Formerly known as BioLayer Corporation Limited. The Group's principal activities are developing and commercialising specialised surfaces used in the development and manufacture of immunoassays.
The company attenpts to convert novel biomarkers into clinical tools that predict, diagnose and track diseases and monitor therapeutic effects. In the process, data is aimed to be generated for the rapidly evolving and human healthcare information business.
Parnterships include:
Prince of Wales Medical Research Institute (POWMRI) - Parkinson's Disease
Manawatu Diagnostics Ltd. (ovarian monitoring)
Bangs Laboratories, Inc. based in the USA
The Board of Anteo announced that it has agreed on the terms of a “Non-Exclusive Supply Agreement” with Merck Chimie SAS which was announced in July 2010 -no revenue estimates provided at the time of eth announcement.
Other Efforts have included:
Work with Alzyhme to develop a novel Alzheimer's blood test.